Other Guidelines | Page 34 | European Cystic Fibrosis Society (ECFS)

How does chronic rhinosinusitis impact quality of life of cystic fibrosis patients?

Drug levels and dosing recommendations for antibiotics used to treat Mycobacterium avium complex in people with cystic fibrosis.

Cystic fibrosis liver disease – A clinical challenge in the era of improved outcomes.

A microengineered laboratory model of human CF lung

Serodiagnostic as a complement to bacterial culture in identification of Mycobacterium abscessus infections in cystic fibrosis patients

Changes in inpatient episodes following the introduction of modulator therapy across different age groups in the USA

Coping and Length of Life in Cystic Fibrosis

Magnetic Resonance Imaging Detects Improvements of Pulmonary and Paranasal Sinus Abnormalities in Response to Elexacaftor/Tezacaftor/Ivacaftor Therapy in Adults with Cystic Fibrosis

Human airway cell models to study genes contributing to CF lung disease

Men’s Sexual and Reproductive Health in Cystic Fibrosis in the Era Highly Effective Modulator Therapies: A Qualitative Study

first
previous
…
30
31
32
33
34
35
36
37
38
…
next
last